Merck/Bayer's Vericiguat Could Bring A New Dynamic For Heart Failure

 
• By Jessica Merrill

The Phase III VICTORIA study evaluating the safety of the sGC stimulator met its primary endpoint.

Autumn red leaf with cut heart in a hand - Image
Vericiguat helped certain patients with chronic heart failure in a Phase III study • Source: Shutterstock

More from Archive

More from Scrip